Stocks Health care APLM
NASDAQ · Health careApollomics Inc. (APLM)
Apollomics Inc. reported revenue of $0 in fiscal 2024. It posted a net loss of $53.9M. In fiscal 2024 capital spending exceeded operating cash flow by $28.8M. At December 31, 2024 it held $9.8M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 24, 2026.
Key facts about Apollomics Inc.
- Net worth
- Apollomics Inc. has a market value (market cap) of $52.9M at the latest share price, and shareholders' equity of $4.9M on its balance sheet at December 31, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2024 revenue was $0, with a net loss of $53.9M.
- Cash flow
- In fiscal 2024 operations used $28.7M of cash.
- Latest report
- The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on April 24, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What Apollomics Inc. does
Apollomics Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker APLM.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | $0 | -$53.9M | -$52.80 | -$28.8M |
| 2023 | $0 | -$172.6M | -$231.99 | -$43.2M |
| 2022 | $0 | -$240.8M | -$844.95 | -$43.2M |
| 2022 | $0 | -$94.8M | -$337.38 | -$43.4M |
| 2020 | $0 | -$74.8M | -$308.04 | -$35.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Apollomics Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 17, 2026Activist stake changed SCHEDULE 13D/A
- August 14, 2026Activist stake changed SCHEDULE 13D/A
- August 12, 2026
- July 21, 2026
- July 14, 2026
- June 24, 2026
- May 15, 2026Form F-3/A filing F-3/A
- April 27, 2026
- April 24, 2026Annual report (foreign issuer) 20-F · period to December 31, 2025
- April 8, 2026Activist stake (5% or more) SCHEDULE 13D
Insider trades
What the people running Apollomics Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $8.3M worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 15, 2026 | Yen Hung HsienDirector | Exercised options | 500 | - |
| September 15, 2026 | Lin Peter Kuan-HowChief Financial Officer | Exercised options | 10,000 | - |
| September 15, 2026 | Lin Peter Kuan-HowChief Financial Officer | Shares withheld for tax | 3,416 | $82.1K |
| September 15, 2026 | Chen Yi-KueiChief Operating Officer, Director | Exercised options | 5,000 | - |
| September 15, 2026 | Chen Hung-WenChief Executive Officer, Director, 10% owner | Exercised options | 5,000 | - |
| September 15, 2026 | Yen Hung HsienDirector | Exercised options | 500 | - |
| September 15, 2026 | Tsai Hsien-ShuDirector | Exercised options | 500 | - |
| September 15, 2026 | Chen Yi-KueiChief Operating Officer, Director | Exercised options | 5,000 | - |
Who owns APLM
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Hung-Wen Chen13D, may seek influence with 1 related filers | 49.76% | August 17, 2026 |
| OrbiMed Advisors II Limited13D, may seek influence with 2 related filers | 18.1% | November 20, 2023 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 4 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Citadel Advisors LLC | 10,664 | new |
| SBI Securities Co., Ltd. | 9 | 0 |
| UBS Group AG | 2 | -140 |
| BlackRock, Inc. | 1 | 0 |
Insiders
9 insiders reported holding 1,661,060 shares in total, about $30.3M at the last price.
| Holder | Shares |
|---|---|
| Chen Hung-WenChief Executive Officer, Director, 10% owner | 1,453,0291,029,695 held indirectly |
| Chen Yi-KueiChief Operating Officer, Director | 141,348121,248 held indirectly |
| Lin Peter Kuan-HowChief Financial Officer | 55,563 |
| Chen Hong-JungDirector | 4,120 |
| Tsai Hsien-ShuDirector | 2,000 |
| Chu Yi-AnDirector | 1,500 |
| Huang Ya-ChiDirector | 1,500 |
| Jan Chen-HuanDirector | 1,500 |
| Yen Hung HsienDirector | 500 |
Questions about APLM
What does Apollomics Inc. do?
Apollomics Inc. is a company in the Health care sector, listed on NASDAQ as APLM. Its shares trade on NASDAQ under the ticker APLM.
What is Apollomics Inc.'s net worth?
Apollomics Inc. has a market value (market cap) of $52.9M at the latest share price, and shareholders' equity of $4.9M on its balance sheet at December 31, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Apollomics Inc. profitable?
No. In fiscal 2024 it reported a net loss of $53.9M.
How much revenue does Apollomics Inc. make?
In fiscal 2024 Apollomics Inc. reported revenue of $0.
When did Apollomics Inc. last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 24, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the insider trade (amended) from September 24, 2026.
Similar companies
Compare APLM with
Follow APLM
Get an email when Apollomics Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Apollomics Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.